Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma. | Cancer | 2015 | 0.76 |
2 | A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma. | Cancer Med | 2016 | 0.76 |